Clinical Trials Browser

Phase 2 × Serotonin 5-HT3 Receptor Antagonists × Clear all

NCT06780085 2026-05-26

MK-3475-01H

Phase 2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT04430361 2020-06-12

the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Phase 2 Unknown

Neoplasms, Vomiting